NovaRad has recently received U.S. Food and Drug Administration (FDA)clearance for reading and interpreting mammography studies for its NovaPACS which is used for the distribution and viewing of mammography studies, including window,level,zoom and volumetric measurements.
If you enjoy this content, please share it with a colleague
Related Content
Dec. 1, 2025 — A study of data from seven outpatient facilities in the New York region found that 20-24% of all the ...
Nov. 27, 2025— AdvaHealth Solutions is highlighting AdvaPACS, its cloud-native and AI-forward imaging platform at RSNA ...
Nov. 6, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, recently announced that Volpara ...
Oct. 28, 2025 — QT Imaging Holdings, Inc., a medical device company focused on radiation-free imaging technology, has ...
Despite decades of progress in breast imaging, one challenge continues to test even the most skilled radiologists ...
Aug. 12, 2025 — Fujifilm Healthcare Americas Corp. has announced that a leading health system with hospital sites ...
March 10, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a ...
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
Dec. 17, 2024 — Radin Health, a provider of advanced radiology AI-Powered solutions, highlighted its All-in-One ...
July 29, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced a ...
December 02, 2025 